Advertisement

Journal of Assisted Reproduction and Genetics

, Volume 32, Issue 9, pp 1317–1323 | Cite as

Dexamethasone attenuates the embryotoxic effect of endometriotic peritoneal fluid in a murine model

  • Ryan J. Heitmann
  • Kyle J. Tobler
  • Laurie Gillette
  • Juan Tercero
  • Richard O. Burney
Reproductive Physiology and Disease
  • 119 Downloads

Abstract

Purpose

The in vitro fertilization (IVF) pregnancy rate of women with advanced stage endometriosis is nearly half that of the general population, suggesting incomplete targeting of the pathophysiology underlying endometriosis-associated infertility. Compelling evidence highlights inflammation as the etiologic link between endometriosis and infertility and a potential target for adjunctive treatment. The objective of this study was to examine the effect of dexamethasone on murine embryos exposed to human endometriotic peritoneal fluid (PF) using the established murine embryo assay model.

Methods

PF was obtained from women with and without severe endometriosis. Murine embryos were harvested and randomly allocated to five groups of culture media conditions: (1) human tubal fluid (HTF), (2) HTF and 10 % PF from women without endometriosis, (3) HTF and 10 % PF from women with endometriosis (PF-E), (4) HTF with PF-E and 0.01 mcg/mL dexamethasone, and (5) HTF with PF-E and 0.1 mcg/mL dexamethasone. Embryos were cultured in standard conditions and evaluated for blastocyst development.

Results

A total of 266 mouse embryos were cultured. Baseline blastulation rates were 63.6 %. The addition of peritoneal fluid from women with endometriosis decreased the blastocyst development rate to 38.9 % (P = 0.008). The addition of 0.1 mcg/mL of dexamethasone to the culture media restored the blastulation rate to near baseline levels (61.2 %; P = 0.019).

Conclusions

The results of our in vitro study demonstrate the capacity of dexamethasone to mitigate the deleterious impact of endometriotic PF on embryo development. If confirmed in vivo, dexamethasone may prove a useful adjunct for the treatment of endometriosis-associated infertility.

Keywords

Endometriosis Infertility Dexamethasone Embryo Blastocyst 

References

  1. 1.
    Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstet Gynecol Clin N Am. 1997;24(2):235–58.CrossRefGoogle Scholar
  2. 2.
    Barnhart K, Dunsmoor-Su R, Coutifaris C. Effect of endometriosis on in vitro fertilization. Fertil Steril. 2002;77(6):1148–55.CrossRefPubMedGoogle Scholar
  3. 3.
    Halis G, Arici A. Endometriosis and inflammation in infertility. Ann N Y Acad Sci. 2004;1034:300–15.CrossRefPubMedGoogle Scholar
  4. 4.
    Ho HN, Wu MY, Chao KH, Chen CD, Chen SU, Chen HF, et al. Decrease in interferon gamma production and impairment of T-lymphocyte proliferation in peritoneal fluid of women with endometriosis. Am J Obstet Gynecol. 1996;175(5):1236–41.CrossRefPubMedGoogle Scholar
  5. 5.
    Oral E, Olive DL, Arici A. The peritoneal environment in endometriosis. Hum Reprod Update. 1996;2(5):385–98.CrossRefPubMedGoogle Scholar
  6. 6.
    Prough SG, Aksel S, Gilmore SM, Yeoman RR. Peritoneal fluid fractions from patients with endometriosis do not promote two-cell mouse embryo growth. Fertil Steril. 1990;54(5):927–30.PubMedGoogle Scholar
  7. 7.
    Morcos RN, Gibbons WE, Findley WE. Effect of peritoneal fluid on in vitro cleavage of 2-cell mouse embryos: possible role in infertility associated with endometriosis. Fertil Steril. 1985;44(5):678–83.PubMedGoogle Scholar
  8. 8.
    Wu MY, Chen SU, Chao KH, Chen CD, Yang YS, Ho HN. Mouse embryo toxicity of IL-6 in peritoneal fluids from women with or without endometriosis. Acta Obstet Gynecol Scand. 2001;80(1):7–11.PubMedGoogle Scholar
  9. 9.
    Gomez-Torres MJ, Acien P, Campos A, Velasco I. Embryotoxicity of peritoneal fluid in women with endometriosis. Its relation with cytokines and lymphocyte populations. Hum Reprod. 2002;17(3):777–81.CrossRefPubMedGoogle Scholar
  10. 10.
    Esfandiari N, Falcone T, Goldberg JM, Agarwal A, Sharma RK. Effects of peritoneal fluid on preimplantation mouse embryo development and apoptosis in vitro. Reprod BioMed Online. 2005;11(5):615–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Noordin L, San GT, Singh HJ, Othman MS, Hafizah W. Pyruvate reduces in vitro the embryotoxic effect of peritoneal fluid from infertile women with endometriosis. Eur J Obstet Gynecol Reprod Biol. 2008;136(1):67–73.CrossRefPubMedGoogle Scholar
  12. 12.
    Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids–new mechanisms for old drugs. N Engl J Med. 2005;353(16):1711–23.CrossRefPubMedGoogle Scholar
  13. 13.
    Eyster KM, Klinkova O, Kennedy V, Hansen KA. Whole genome deoxyribonucleic acid microarray analysis of gene expression in ectopic versus eutopic endometrium. Fertil Steril. 2007;88(6):1505–33.CrossRefPubMedGoogle Scholar
  14. 14.
    Verhoog NJ, Du Toit A, Avenant C, Hapgood JP. Glucocorticoid-independent repression of tumor necrosis factor (TNF) alpha-stimulated interleukin (IL)-6 expression by the glucocorticoid receptor: a potential mechanism for protection against an excessive inflammatory response. J Biol Chem. 2011;286(22):19297–310.PubMedCentralCrossRefPubMedGoogle Scholar
  15. 15.
    Bider D, Amoday I, Tur-Kaspa I, Livshits A, Dor J. The addition of a glucocorticoid to the protocol of programmed oocyte retrieval for in-vitro fertilization–a randomized study. Hum Reprod. 1996;11(8):1606–8.CrossRefPubMedGoogle Scholar
  16. 16.
    Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril. 1997;67(5):817-21.Google Scholar
  17. 17.
    Fassbender A, Vodeolaskaia A, Saunders P, Lebovic D, Waelkens E, De Moor B, et al. Biomarkers of endometriosis. Fertil Steril. 2013;99(4):1135–45.CrossRefPubMedGoogle Scholar
  18. 18.
    Noyes R, Hertig A, Rock J. Dating the endometrial biopsy. Am J Obstet Gynecol. 1975;122:262–3.PubMedGoogle Scholar
  19. 19.
    Byers SL, Payson SJ, Taft RA. Performance of ten inbred mouse strains following assisted reproductive technologies (ARTs). Theriogenology. 2006;65(9):1716–26.CrossRefPubMedGoogle Scholar
  20. 20.
    Nagy A, Gertsenstein M, Vintersten K, Behringer R. Manipulating the Mouse Embryo: a laboratory manual. New York: Cold Spring Harbor Laboratory Press; 2003.Google Scholar
  21. 21.
    Lane M, Gardner DK. Effect of incubation volume and embryo density on the development and viability of mouse embryos in vitro. Hum Reprod. 1992;7(4):558–62.PubMedGoogle Scholar
  22. 22.
    Lawitts JA, Biggers JD. Culture of preimplantation embryos. Methods Enzymol. 1993;225:153–64.CrossRefPubMedGoogle Scholar
  23. 23.
    Navarro J, Garrido N, Remohi J, Pellicer A. How does endometriosis affect infertility? Obstet Gynecol Clin N Am. 2003;30(1):181–92.CrossRefGoogle Scholar
  24. 24.
    Simon C, Gutierrez A, Vidal A, Santos MJ d l, Tarin JJ, Remohi J, et al. Outcome of patients with endometriosis in assisted reproduction: results from in-vitro fertilization and oocyte donation. Hum Reprod. 1994;9(4):725–9.PubMedGoogle Scholar
  25. 25.
    Ding GL, Chen XJ, Luo Q, Dong MY, Wang N, Huang HF. Attenuated oocyte fertilization and embryo development associated with altered growth factor/signal transduction induced by endometriotic peritoneal fluid. Fertil Steril. 2010;93(8):2538–44.CrossRefPubMedGoogle Scholar
  26. 26.
    Mansour G, Abdelrazik H, Sharma RK, Radwan E, Falcone T, Agarwal A. L-carnitine supplementation reduces oocyte cytoskeleton damage and embryo apoptosis induced by incubation in peritoneal fluid from patients with endometriosis. Fertil Steril. 2009;91(5 Suppl):2079–86.CrossRefPubMedGoogle Scholar
  27. 27.
    Hauzman EE, Garcia-Velasco JA, Pellicer A. Oocyte donation and endometriosis: what are the lessons? Semin Reprod Med. 2013;31(2):173–7.CrossRefPubMedGoogle Scholar
  28. 28.
    Simon C, Gomez E, Mir A, Santos MJ D l, Pellicer A. Glucocorticoid treatment decreases sera embryotoxicity in endometriosis patients. Fertil Steril. 1992;58(2):284–9.PubMedGoogle Scholar
  29. 29.
    Bider D, Hourvitz A, Tur Kaspa I, Dirnfeld M, Dor J. Dexamethasone supplementation to gonadotropin stimulation for in vitro fertilization in polycystic ovarian disease. J Assist Reprod Genet. 1999;16(5):233–5.PubMedCentralCrossRefPubMedGoogle Scholar
  30. 30.
    Keay SD, Lenton EA, Cooke ID, Hull MG, Jenkins JM. Low-dose dexamethasone augments the ovarian response to exogenous gonadotrophins leading to a reduction in cycle cancellation rate in a standard IVF programme. Hum Reprod. 2001;16(9):1861–5.CrossRefPubMedGoogle Scholar
  31. 31.
    Czock D, Keller F, Rasche FM, Haussler U. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet. 2005;44(1):61–98.CrossRefPubMedGoogle Scholar
  32. 32.
    Lamiable D, Vistelle R, Sulmont V, Millart H, Caron J, Choisy H. Pharmacokinetics of dexamethasone administered orally in obese patients. Therapie. 1990;45(4):311–4.PubMedGoogle Scholar
  33. 33.
    Van Merris V, Van Wemmel K, Cortvrindt R. In vitro effects of dexamethasone on mouse ovarian function and pre-implantation embryo development. Reprod Toxicol. 2007;23(1):32–41.CrossRefPubMedGoogle Scholar
  34. 34.
    Sasson R, Amsterdam A. Pleiotropic anti-apoptotic activity of glucocorticoids in ovarian follicular cells. Biochem Pharmacol. 2003;66(8):1393–401.CrossRefPubMedGoogle Scholar
  35. 35.
    Kumar S, Allen DA, Kieswich JE, Patel NS, Harwood S, Mazzon E, et al. Dexamethasone ameliorates renal ischemia-reperfusion injury. J Am Soc Nephrol : JASN. 2009;20(11):2412–25.PubMedCentralCrossRefPubMedGoogle Scholar
  36. 36.
    Korgun ET, Dohr G, Desoye G, Demir R, Kayisli UA, Hahn T. Expression of insulin, insulin-like growth factor I and glucocorticoid receptor in rat uterus and embryo during decidualization, implantation and organogenesis. Reproduction (Cambridge, England). 2003;125(1):75–84.CrossRefGoogle Scholar
  37. 37.
    Siemieniuch MJ, Majewska M, Takahashi M, Sakatani M, Lukasik K, Okuda K, et al. Are glucocorticoids auto- and/or paracrine factors in early bovine embryo development and implantation? Reprod Biol. 2010;10(3):249–56.CrossRefPubMedGoogle Scholar
  38. 38.
    Pampfer S, Wuu YD, Vanderheyden I, De Hertogh R. Expression of tumor necrosis factor-alpha (TNF alpha) receptors and selective effect of TNF alpha on the inner cell mass in mouse blastocysts. Endocrinology. 1994;134(1):206–12.PubMedGoogle Scholar
  39. 39.
    Ben-Yair E, Less A, Lev S, Ben-Yehoshua L, Tartakovsky B. Tumour necrosis factor alpha binding to human and mouse trophoblast. Cytokine. 1997;9(11):830–6.CrossRefPubMedGoogle Scholar
  40. 40.
    Kohchi C, Tanabe Y, Noguchi K, Mizuno D, Soma G. Induction of differentiation in embryonic stem cells by 26-kD membrane-bound tumor necrosis factor (TNF) and 17-kD free TNF. In vivo (Athens, Greece). 1996;10(1):19-27.Google Scholar
  41. 41.
    Wuu YD, Pampfer S, Vanderheyden I, Lee KH, De Hertogh R. Impact of tumor necrosis factor alpha on mouse embryonic stem cells. Biol Reprod. 1998;58(6):1416–24.CrossRefPubMedGoogle Scholar
  42. 42.
    Pampfer S, Vanderheyden I, McCracken JE, Vesela J, De Hertogh R. Increased cell death in rat blastocysts exposed to maternal diabetes in utero and to high glucose or tumor necrosis factor-alpha in vitro. Development (Cambridge, England). 1997;124(23):4827–36.Google Scholar

Copyright information

© Springer Science+Business Media New York (outside the USA) 2015

Authors and Affiliations

  • Ryan J. Heitmann
    • 1
  • Kyle J. Tobler
    • 1
  • Laurie Gillette
    • 2
  • Juan Tercero
    • 2
  • Richard O. Burney
    • 1
    • 2
    • 3
  1. 1.Department of Obstetrics and GynecologyMadigan Army Medical CenterTacomaUSA
  2. 2.Department of Clinical InvestigationMadigan Army Medical CenterTacomaUSA
  3. 3.Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and GynecologyMadigan Healthcare SystemsTacomaUSA

Personalised recommendations